UnknownNCT03509701

Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster Virus

Studying Reversible cerebral vasoconstriction syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Asan Medical Center
Principal Investigator: Sung-Han Kim, MD.Phd
Asan Medical Center
Intervention: VZV-specific antibody response from blood(diagnostic_test)
Enrollment: 40 target
Eligibility: 20-79 years · All sexes
Timeline: 2018 – 2020

Study locations (1)

Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Collaborators

Hanyang University · Eulji University Hospital · Kangbuk Samsung Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03509701 on ClinicalTrials.gov

Other trials for Reversible cerebral vasoconstriction syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT04179383
Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome
University Hospital, Montpellier

See all trials for Reversible cerebral vasoconstriction syndrome →

← Back to all trials